image

"We cannot win the battle against AIDS if we do not also fight TB. TB is too often a death sentence for people with AIDS."

Nelson Mandela, July 2004

News

SATVI gets approval from USA based clinical research organisation

PDFPrint

SATVI gets site approval from USA based clinical research organisation

Scientists at the UCT based South African Tuberculosis Vaccine Initiative (SATVI) were ecstatic with the announcement by the Division of AIDS (DAIDS) of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), USA that SATVI meets it’s stringent requirements for participation in international clinical trials. On Tuesday 19 August 2014, the DAIDS Branch Chief, Ms Donna Germuda announced that “SATVI has met all the stringent requirements of the DAIDS site approval process”.

SATVI Site Accreditation DAIDS 19 August 2014

   

18 August 2014 Vacancy Clinical Immunologist

PDFPrint

The South African Tuberculosis Vaccine Initiative (SATVI) calls for applications for a vacancy as Clinical Immunologist at the level of Senior Lecturer/Associate Professor.  Applications close: 8 September 2014. Click on the link to download the advert.

http://www.uct.ac.za/usr/about/intro/vacancies/execacad/2014/FHS_14100_SATVI_ClinicalImmunologist_Aug14.pdf

 

   

18 August 2014 Vacancy Study Coordinator

PDFPrint

SATVI invites applications for the vacancy as Study Coordinator at the Worcester site. CLOSING DATE  1 September 2014.

Click here to download advert: http://www.uct.ac.za/usr/about/intro/vacancies/researchpass/2014/FHS_14101_SATVI_StudyCoord_Aug14.pdf

 

   

4 August 2014 Joint collaboration between UCT biomedical research units to expose children to the world of biomedical TB research.

PDFPrint
In a unique collaboration between five research units attached to the Institute of Infectious Disease and Molecular Medicine (IDM) in the Faculty of Health Sciences, research laboratory staff have joined forces in developing and rolling out a training program which empowers children with knowledge about the biomedical world and practical media skills. The public engagement program, funded by the Wellcome Trust, was developed by IDM students Anastasia Koch, Zanele Ditse, Olivia Carulei and Hanif Esmail, in close collaboration with local artists Ed Young and Herman de Klerk, with the support of staff from the South African Tuberculosis Vaccine Initiative (SATVI), the Clinical Infectious Diseases Research Initiative (CIDRI), the Desmond Tutu HIV Centre (DTHC) and the Molecular Mycobacteriology Research Unit (MMRU).
10575120 1447382052192332 2721669556670553911 o

According to Anastasia Koch, PhD student attached to the Molecular Mycobacteriology Research Unit of the University of Cape Town, “the project started in an organic, informal way as part of the UCT Post-Graduate Student Council,
   

14 August 2014- SATVI Accredited as UCT Research Site

PDFPrint
SATVI accredited as a University of Cape Town Research Centre

“SATVI has a world-beating track record of successful TB vaccine trials, coupled with highly innovative TB immunology studies, which together are responsible for the group’s increased publication output in high impact journals”
Picture Mark Announcement SATVI research centre
The South African Tuberculosis Vaccine Initiative (SATVI) has joined the ranks of established UCT research groupings with the approval of its accreditation as a Research Centre of the University of Cape Town. According to Professor Mark Hatherill, SATVI Director, the organisation has just received the exciting news that SATVI has been awarded formal accreditation as a Research Centre by the University of Cape Town.He said “accreditation offers major benefits for the organisation, which will gain from an improved governance environment, five-yearly cycles of strategic review, and the potential to leverage additional funding for students and post-doctoral fellows.
   

SATVI Director departs from UCT to focus on global TB Strategy at Bill Gates Foundation

PDFPrint

Group Staff Picture

Handover Picune 2014

Professor Willem Hanekom, who has been with the South African Tuberculosis Vaccine Initiative (SATVI) for the past eight years, recently said his farewells to staff, friends and colleagues at the University of Cape Town, before taking up a key position at the Bill and Melinda Gates Foundation, where he will be focusing on the development of a global policy for TB vaccine development.

Willem who has been appointed Deputy Director, Program lead for TB Vaccines, at the Seattle based Bill Gates Foundation, was the Director of SATVI since 2011 and has vast expertise in clinical trials involving protective host responses to TB and has contributed to more than 120 publications. Willem is past president of the Federation of African Immunological Societies, and has served on multiple international advisory committees in TB vaccine development and translational immunology.

   

SATVI Appoints New Director

PDFPrint

It is my great pleasure to announce the appointment of SATVI's new Director! Congratulations to Associate Professor Mark Hatherill on his appointment!!!

There has been a formal process which involved several stakeholders at the University to appoint our new Director. Mark will be formally inaugurated at an upcoming staff meeting but we would like to thank Professor Mizrahi and Professor Hussey for their support during this transition.

We would like to thank Willem for building a solid foundation at SATVI during his tenure and developing a clear strategy. We are really excited about the next chapter at SATVI under Mark's Leadership.

We are ALL looking forward to working with Mark in achieving our vision of 'A World without TB'.

Kind Regards
Zameer on behalf of Exco

   

Applications for a postdoctoral fellowship in systems immunology

PDFPrint

We are inviting applications for a postdoctoral fellowship in systems immunology to conduct research on a large project aimed at identifying and validating immune correlates of risk of TB in collaboration with global leaders in systems biology at Seattle Biomedical Research Institute.

For more information click here

   

Petition SADC nations to prioritize TB R&D for new drugs, diagnostics and vaccines

PDFPrint

Join us and Aeras in asking SADC nations to prioritize TB R&D for new drugs, diagnostics and vaccines in the Declaration on TB in the Mining Sector.

http://aeras.org/petition

   

Applications for masters or doctoral students

PDFPrint

We are inviting applications for masters or doctoral students to work on clinical immunology of tuberculosis projects.

For more information click here